Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines

INDROVÁ, M., BUBENÍK, J., MIKYŠKOVÁ, R., MENDOZA, L., ŠÍMOVÁ, J., BIEBLOVÁ, J., JANDLOVÁ, T., JINOCH, P., ŠMAHEL, M., VONKA, V., PAJTASZ-PIASECKA, E. Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines. International Journal of Oncology. 2003, 22(3), 691-695. ISSN 1019-6439. E-ISSN 1791-2423.